Risk Factors for Low Immune Recovery Among Participants with CD4+ Counts > 500 cells/mm 3 who Achieved Viral Suppression in the Immediate Antiretrovrial Treatment (ART) Group in Strategic Timing of AntiRetroviral Treatment (START) Trial
Open Forum Infectious Diseases（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要